Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Monotherapy vs Paclitaxel-Carboplatin as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression
NCT07401654Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in ovarian cancer, sponsored by Sun Yat-sen Memorial Hospital. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT07401654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07401654.